Yesterday I had the opportunity to present NurExone Biologic‘s technology at the ILANIT/FISEB Conference, during a session called “Latest advances in extracellular vesicles: from bench to bedside”. It is amazing to see the growing interest in EVs both in academia an in the Biomed Industry, and this year for the first time
Yesterday, our Chief scientific advisor Prof. Shulamit Levenberg presented our company at the The Peres Center for Peace and Innovation in an event called “Women Creating Scientific Innovations”. NurExone Biologic is one of the three spin-out companies that came out of the Levenberg Lab together with Aleph Farms and Nanosynex.
Great trip to Canada and New York for NurExone Biologic‘s team! 👏🏻 One of the challenges as a company that operates in Israel and is publicly traded in Canada is to get to know the local market and have the players get to know us! Thanks team for this huge leap
Meet our CEO Dr. Lior Shaltiel, PhD, CFO Eran Ovadya and Head of Communications and Investor Relations Inbar Paz Benayoun, Adv. to hear more of NurExone Biologic recent activity!
